Development of HIV vectors for anti-HIV gene therapy.
Current gene therapy protocols for HIV infection use transfection or murine retrovirus mediated transfer of antiviral genes into CD4+ T cells or CD34+ progenitor cells ex vivo, followed by infusion of the gene altered cells into autologous or syngeneic/allogeneic recipients. While these studies are...
Salvato in:
| Pubblicato in: | Proc Natl Acad Sci U S A |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
National Academy of Sciences
1996
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38068/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8876146/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.21.11395 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|